<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>KULeuven: Judging Session</title>
        <link>https://video.igem.org/videos/watch/4bf28630-24fd-48ba-a854-b2680ac9d4ba</link>
        <description>Polyendocrine Metabolic Ovarian Syndrome (PMOS) affects 1 in 8 women of reproductive age. Despite its prevalence, no approved disease-modifying treatment exists. Emerging evidence implicates the involvement of the intestinal microbiome. We hypothesize that microbial shifts alter the bile acid pool, contributing to metabolic dysfunction, inflammation, hyperandrogenism, and reproductive complications. Since the gut commensal Phocaeicola vulgatus is reportedly enriched in PMOS patients, bile salt hydrolase (BSH) levels rise in parallel, resulting in alterations of bile acid composition and downstream signaling. Rather than eliminating this bacterium, we aim to engineer it to specifically modulate bile acid metabolism. To overcome the limited genetic tools available for this non-model anaerobe, we developed a synthetic biology toolkit featuring characterized promoters evaluated using four fluorescent reporters, optimized conjugation, and phenotypic characterization of potential chassis strains. Building on this, we developed EMPOWER, designed to selectively modulate BSH activity in P. vulgatus to restore beneficial bile acid signaling.</description>
        <lastBuildDate>Fri, 20 Nov 2026 21:53:14 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>PeerTube - https://video.igem.org</generator>
        <image>
            <title>KULeuven: Judging Session</title>
            <url>https://video.igem.org/client/assets/images/icons/icon-1500x1500.png</url>
            <link>https://video.igem.org/videos/watch/4bf28630-24fd-48ba-a854-b2680ac9d4ba</link>
        </image>
        <copyright>All rights reserved, unless otherwise specified in the terms specified at https://video.igem.org/about and potential licenses granted by each content's rightholder.</copyright>
        <atom:link href="https://video.igem.org/feeds/video-comments.xml?videoId=4bf28630-24fd-48ba-a854-b2680ac9d4ba" rel="self" type="application/rss+xml"/>
    </channel>
</rss>